BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,610,257 | -29.6% | 307,638 | -24.4% | 0.07% | -29.8% |
| Q2 2023 | $16,499,847 | 0.0% | 406,801 | 0.0% | 0.09% | 0.0% |
| Q1 2023 | $16,499,847 | -29.5% | 406,801 | -11.4% | 0.09% | -31.4% |
| Q4 2022 | $23,397,421 | -7.3% | 459,043 | -2.0% | 0.14% | -13.8% |
| Q3 2022 | $25,231,000 | -17.7% | 468,460 | -1.9% | 0.16% | -11.7% |
| Q2 2022 | $30,664,000 | -20.1% | 477,421 | -3.5% | 0.18% | -4.3% |
| Q1 2022 | $38,374,000 | -10.1% | 494,904 | -0.5% | 0.19% | -7.4% |
| Q4 2021 | $42,700,000 | +4.8% | 497,444 | -1.8% | 0.20% | -3.8% |
| Q3 2021 | $40,758,000 | -1.7% | 506,761 | -1.6% | 0.21% | -1.4% |
| Q2 2021 | $41,470,000 | -6.0% | 515,175 | -1.6% | 0.21% | -10.1% |
| Q1 2021 | $44,133,000 | +4.8% | 523,297 | -0.3% | 0.24% | +2.6% |
| Q4 2020 | $42,128,000 | -0.6% | 525,040 | -0.3% | 0.23% | -8.7% |
| Q3 2020 | $42,369,000 | -7.4% | 526,863 | -0.8% | 0.25% | -9.3% |
| Q2 2020 | $45,749,000 | -3.6% | 531,359 | -6.3% | 0.28% | +29.6% |
| Q1 2020 | $47,441,000 | 0.0% | 567,347 | 0.0% | 0.22% | 0.0% |
| Q4 2019 | $47,441,000 | -29.0% | 567,347 | -25.7% | 0.22% | -29.4% |
| Q3 2019 | $66,819,000 | +48.2% | 763,927 | +38.7% | 0.31% | +54.5% |
| Q2 2019 | $45,101,000 | -0.3% | 550,711 | -1.0% | 0.20% | -3.4% |
| Q1 2019 | $45,245,000 | +10.7% | 556,477 | -10.4% | 0.20% | +3.0% |
| Q4 2018 | $40,856,000 | -17.5% | 620,756 | -3.3% | 0.20% | +0.5% |
| Q3 2018 | $49,509,000 | +6.8% | 642,234 | +2.3% | 0.20% | -3.4% |
| Q2 2018 | $46,347,000 | +10.5% | 627,675 | -3.3% | 0.20% | +17.1% |
| Q1 2018 | $41,951,000 | 0.0% | 649,022 | 0.0% | 0.18% | 0.0% |
| Q4 2017 | $41,951,000 | -10.7% | 649,022 | -13.4% | 0.18% | -15.0% |
| Q3 2017 | $47,002,000 | +8.7% | 749,045 | -10.2% | 0.21% | -0.5% |
| Q2 2017 | $43,253,000 | 0.0% | 834,054 | 0.0% | 0.21% | 0.0% |
| Q1 2017 | $43,253,000 | +16.3% | 834,054 | -0.6% | 0.21% | +2.5% |
| Q4 2016 | $37,195,000 | -5.4% | 838,901 | +1.5% | 0.20% | -9.0% |
| Q3 2016 | $39,333,000 | +5.9% | 826,352 | +0.6% | 0.22% | -1.3% |
| Q2 2016 | $37,142,000 | +12.9% | 821,411 | +2.6% | 0.22% | +5.6% |
| Q1 2016 | $32,897,000 | +16.3% | 800,841 | +8.0% | 0.21% | +10.4% |
| Q4 2015 | $28,285,000 | +68.8% | 741,427 | +45.4% | 0.19% | +56.9% |
| Q3 2015 | $16,756,000 | -61.1% | 510,090 | -17.3% | 0.12% | -60.5% |
| Q2 2015 | $43,107,000 | -4.9% | 616,449 | -6.8% | 0.31% | -5.8% |
| Q1 2015 | $45,306,000 | -2.4% | 661,423 | +4.4% | 0.33% | -9.3% |
| Q4 2014 | $46,415,000 | -12.5% | 633,314 | -14.3% | 0.36% | -21.7% |
| Q3 2014 | $53,027,000 | +0.0% | 738,871 | +0.8% | 0.46% | -2.3% |
| Q2 2014 | $53,021,000 | -0.7% | 733,369 | +1.0% | 0.48% | -4.0% |
| Q1 2014 | $53,413,000 | +4.8% | 725,932 | -1.0% | 0.50% | -4.8% |
| Q4 2013 | $50,975,000 | +16.3% | 732,958 | +9.8% | 0.52% | +0.2% |
| Q3 2013 | $43,840,000 | -11.2% | 667,394 | -6.4% | 0.52% | -15.4% |
| Q2 2013 | $49,388,000 | +1446.8% | 713,001 | +1521.7% | 0.62% | +118.1% |
| Q1 2013 | $3,193,000 | +2.8% | 43,966 | -5.6% | 0.28% | -11.6% |
| Q4 2012 | $3,105,000 | -19.3% | 46,586 | -27.0% | 0.32% | -24.0% |
| Q3 2012 | $3,847,000 | -46.6% | 63,846 | -49.9% | 0.42% | +6.6% |
| Q1 2012 | $7,201,000 | +117.4% | 127,550 | +90.4% | 0.39% | -13.8% |
| Q4 2011 | $3,313,000 | +2.1% | 66,975 | +15.8% | 0.46% | -14.4% |
| Q3 2011 | $3,246,000 | -10.2% | 57,835 | -4.5% | 0.53% | +4.3% |
| Q2 2011 | $3,615,000 | +17.9% | 60,575 | 0.0% | 0.51% | -3.4% |
| Q4 2010 | $3,066,000 | +6.1% | 60,575 | 0.0% | 0.53% | -4.8% |
| Q3 2010 | $2,890,000 | +36.3% | 60,575 | +16.1% | 0.56% | +25.2% |
| Q2 2010 | $2,120,000 | -12.6% | 52,175 | +25.1% | 0.44% | -2.0% |
| Q1 2010 | $2,426,000 | +5.5% | 41,700 | +6.4% | 0.45% | 0.0% |
| Q4 2009 | $2,300,000 | +3.0% | 39,200 | 0.0% | 0.45% | -0.7% |
| Q3 2009 | $2,234,000 | +7.6% | 39,200 | 0.0% | 0.46% | -6.4% |
| Q2 2009 | $2,076,000 | -13.5% | 39,200 | -16.3% | 0.49% | -28.3% |
| Q1 2009 | $2,400,000 | +12.9% | 46,860 | +18.2% | 0.68% | +26.1% |
| Q4 2008 | $2,125,000 | -51.8% | 39,660 | -41.0% | 0.54% | -36.6% |
| Q3 2008 | $4,412,000 | +150.3% | 67,234 | +143.8% | 0.85% | +174.0% |
| Q2 2008 | $1,763,000 | -21.3% | 27,574 | -28.9% | 0.31% | -9.6% |
| Q1 2008 | $2,241,000 | +44.5% | 38,768 | +40.6% | 0.34% | +63.8% |
| Q3 2007 | $1,551,000 | – | 27,574 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |